ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $26,000 | -13.3% | 14,140 | +31.2% | 0.04% | +3800.0% |
| Q4 2019 | $30,000 | -9.1% | 10,780 | -50.3% | 0.00% | -50.0% |
| Q3 2019 | $33,000 | -55.4% | 21,674 | -38.9% | 0.00% | -50.0% |
| Q2 2019 | $74,000 | -46.0% | 35,449 | -0.6% | 0.00% | -55.6% |
| Q4 2018 | $137,000 | -60.7% | 35,658 | -3.6% | 0.01% | -43.8% |
| Q3 2018 | $349,000 | +384.7% | 36,991 | +155.3% | 0.02% | +433.3% |
| Q1 2018 | $72,000 | -73.3% | 14,491 | -72.9% | 0.00% | -75.0% |
| Q4 2017 | $270,000 | +159.6% | 53,482 | +216.8% | 0.01% | +140.0% |
| Q3 2017 | $104,000 | -24.1% | 16,882 | -25.4% | 0.01% | 0.0% |
| Q3 2015 | $137,000 | – | 22,617 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |